Post-bronchodilator 1-FEV1/FEV3 as a measure of small airway dysfunction in childhood asthma
y. Roh (Seoul, Republic of Korea), H. Kim (Seoul, Republic of Korea), J. Jung (Seoul, Republic of Korea), M. Park (Seoul, Republic of Korea), J. Kim (Seoul, Republic of Korea), M. Kim (Seoul, Republic of Korea), Y. Kim (Seoul, Republic of Korea), M. Sohn (Seoul, Republic of Korea), K. Kim (Seoul, Republic of Korea), S. Kim (Seoul, Republic of Korea)
Source: International Congress 2022 – Finding the way to a correct asthma diagnosis
Session: Finding the way to a correct asthma diagnosis
Session type: Thematic Poster
Number: 978
 
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
y. Roh (Seoul, Republic of Korea), H. Kim (Seoul, Republic of Korea), J. Jung (Seoul, Republic of Korea), M. Park (Seoul, Republic of Korea), J. Kim (Seoul, Republic of Korea), M. Kim (Seoul, Republic of Korea), Y. Kim (Seoul, Republic of Korea), M. Sohn (Seoul, Republic of Korea), K. Kim (Seoul, Republic of Korea), S. Kim (Seoul, Republic of Korea). Post-bronchodilator 1-FEV1/FEV3 as a measure of small airway dysfunction in childhood asthma. 978
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|